Autotrend Partners routes capital, talent, and dealflow between operators who need to find each other.
Private Equity · Wealth · Banking · AI · Pharmaceutical · Coffee Roasters
September 2026 — public data across the markets we track, updated as it publishes.
- 1F.L. Putnam added a $1B AUM Milwaukee advisory team, its 12th deal this year expanding further into the Midwest
- 2Cencora and Cardinal Health spent a combined $6.5B on physician-practice and specialty pharmacy deals this year, pushing the big wholesalers well past traditional distribution
- 3Independent roasters pooling roasting and purchasing power to offset still-elevated green coffee costs
Sourced from WealthManagement.com, Pharmaceutical Commerce, World Coffee Portal, and ICE Arabica futures data.
We put both sides in the room directly — no lists or leads, just vetted introductions at the right time.
Building in the open. We’re working alongside myoProcess — a vetted B2B partner trusted across $1B+ in transactions — while we route our first introductions in this lane. Our first closed match replaces this paragraph.
What we see in this market that outsiders miss.
- Issue 01The Warning Letter Is the Start of the Clock, Not the End
- Issue 02The RIA Rollup Isn’t Buying AUM — It’s Buying the Advisor
- Issue 03On Founder Liquidity Windows
- Issue 04The Coffee Roaster Roll-Up Isn’t Buying Beans — It’s Buying the Route
- Issue 05The Big Three Aren’t Just Moving Pills Anymore — They’re Buying the Prescribers
- Issue 06Timing and Persuasion in B2B MarketsSoon
- Issue 07Thin Markets and High-Leverage IntroductionsSoon